PMID- 12661008 OWN - NLM STAT- MEDLINE DCOM- 20030512 LR - 20231213 IS - 1045-2257 (Print) IS - 1045-2257 (Linking) VI - 37 IP - 1 DP - 2003 May TI - A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene. PG - 79-83 AB - The ETV6 gene is a member of the ETS family of transcription factors and the main target of chromosomal rearrangements affecting chromosome band 12p13. To date, more than 15 fusion partners of ETV6 have been characterized at the molecular level. Most of these fusions encode chimeric proteins with oncogenic properties. However, some of the translocations do not produce a functional fusion protein, but may induce ectopic expression of oncogenes located close to the breakpoint. We herein report the characterization and cloning of a novel cryptic translocation, t(12;17)(p13;p12-p13), occurring in a patient with an acute myeloid leukemia evolving from a chronic myelomonocytic leukemia. Cytogenetic analysis suggested the presence of a deletion of the short arm of chromosome 12, del(12)(p13), in three of the five metaphase cells analyzed. However, fluorescence in situ hybridization (FISH) with the ETV6-specific cosmid clones 179A6, 50F4, 163E7, and 148B6 as well as probes hybridizing to the TP53 gene on 17p13 and the subtelomeric region of 17p revealed the presence of a translocation between 12p and 17p. By FISH, the breakpoints could be localized in intron 1 of ETV6 and centromeric to TP53. By 3' rapid amplification of cDNA ends-polymerase chain reaction (3' RACE-PCR), a fusion transcript between exon 1 of ETV6 and the antisense strand of PER1 (period homolog 1, Drosophila), a circadian clock gene, could be identified. This ETV6-PER1 (antisense PER1 strand) fusion transcript does not produce a fusion protein, and no other fusion transcripts could be detected. We hypothesize that in the absence of a fusion protein, the inactivation of PER1 or deregulation of a gene in the neighborhood of PER1 may contribute to the pathogenesis of leukemias with a t(12;17)(p13;p12-p13). CI - Copyright 2003 Wiley-Liss, Inc. FAU - Murga Penas, Eva Maria AU - Murga Penas EM AD - Department of Medicine, Division of Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. FAU - Cools, Jan AU - Cools J FAU - Algenstaedt, Petra AU - Algenstaedt P FAU - Hinz, Kristina AU - Hinz K FAU - Seeger, Doris AU - Seeger D FAU - Schafhausen, Philippe AU - Schafhausen P FAU - Schilling, Georgia AU - Schilling G FAU - Marynen, Peter AU - Marynen P FAU - Hossfeld, Dieter K AU - Hossfeld DK FAU - Dierlamm, Judith AU - Dierlamm J LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Genes Chromosomes Cancer JT - Genes, chromosomes & cancer JID - 9007329 RN - 0 (Cell Cycle Proteins) RN - 0 (DNA, Antisense) RN - 0 (DNA, Neoplasm) RN - 0 (DNA-Binding Proteins) RN - 0 (Nuclear Proteins) RN - 0 (Oncogene Proteins, Fusion) RN - 0 (PER1 protein, human) RN - 0 (Period Circadian Proteins) RN - 0 (Proto-Oncogene Proteins c-ets) RN - 0 (Repressor Proteins) SB - IM MH - Acute Disease MH - Aged MH - Base Sequence/genetics MH - Cell Cycle Proteins MH - Chromosomes, Human, Pair 12/*genetics MH - Chromosomes, Human, Pair 17/*genetics MH - DNA, Antisense/genetics MH - DNA, Neoplasm/genetics MH - DNA-Binding Proteins/*genetics MH - Humans MH - Leukemia, Myeloid/etiology/*genetics MH - Leukemia, Myelomonocytic, Chronic/genetics MH - Male MH - Molecular Sequence Data MH - Neoplasms, Second Primary/*genetics MH - Nuclear Proteins/*genetics MH - Oncogene Proteins, Fusion/*genetics MH - Period Circadian Proteins MH - Proto-Oncogene Proteins c-ets MH - Repressor Proteins/*genetics MH - Translocation, Genetic/*genetics MH - ETS Translocation Variant 6 Protein EDAT- 2003/03/28 05:00 MHDA- 2003/05/13 05:00 CRDT- 2003/03/28 05:00 PHST- 2003/03/28 05:00 [pubmed] PHST- 2003/05/13 05:00 [medline] PHST- 2003/03/28 05:00 [entrez] AID - 10.1002/gcc.10175 [doi] PST - ppublish SO - Genes Chromosomes Cancer. 2003 May;37(1):79-83. doi: 10.1002/gcc.10175.